Comparison of six thromboplastin reagents in detection of prothrombin time;
6种凝血活酶试剂测定凝血酶原时间评价
In order to study the influence of thromboplastins reagents on the prothrombin time,we use four kinds of reagent to determine some samples from normal and patients who takes oral anticoagulant by manual method.
为了探讨不同来源、不同制备的凝血活酶试剂对凝血酶原时间 (PT)测定结果的影响 ,使用四种不同的凝血活酶试剂以手工方法对正常人及口服抗凝药治疗的病人血浆进行了 PT测定 ,以 INR及 PT秒两种方式报告结果 ,根据不同试剂测定结果分组分段进行统计分析 ,结果表明 ,以 PT秒报告结果时 ,相同的测定方法、相同的标本用不同的凝血活酶试剂测定 ,当 INR<2 。
There are positive correlations between BMD and ChE, positive correlations between BMD and PTA.
慢性乙型肝炎、肝硬化患者由于肝细胞功能损害,出现不同程度的骨代谢异常,通过化验肝功能、胆碱 酯酶(ChE)、凝血酶原活动度(PTA)、血清钙,测量骨密度(BMD),发现慢性乙型肝炎、肝硬化患者骨密度与胆碱酯 酶、凝血酶原活动度正相关,与丙氨酸氨基转移酶(ALT)、胆红素(TBil)无相关性。
The Influence of Different Thromboplastins Upon the International Normalised ratio (INR) and the Prothrombin Time Ratio (PTR)
组织凝血活酶对凝血酶原时间比率与国际正常化比率的影响
Comparison of activated partial thromboplastion time reagent between made by oneself and imported reagent
自制与进口活化部分凝血活酶试剂的比较
Determination standard of abnormal result for activated partial thromboplastin time
活化的部分凝血活酶时间异常结果的判定标准
Calibration of Human Placenta Thromboplastin and it′s Clinical Uses
人胎盘凝血活酶试剂的标定及其临床应用
Change and Clinical Significance of Serum AT-Ⅲ in Patients with Ischemic Stroke Disease
血浆抗凝血活酶Ⅲ活性在急性脑梗死中的变化及其临床意义
Study on the Relationship of Mutation of Prothrombin G20210A,Activated Protein C Resistance and Antithrombin in Patients with Coronary Heart Disease;
凝血酶原G20210A突变、抗活化蛋白C和抗凝血酶与冠心病关系的研究
Prokaryotic Expression,Purification and Procoagulant Activity Analysis of Recombinant Fibrinogen-related Domain Protein of Human fgl2 Prothrombinase
人fgl2凝血酶原酶FRED结构域的原核表达、纯化及其凝血活性的鉴定
Coagulation Activity of Gln49-PLA_2 from Gloydius Ussuriensis Snake Venom in Vitro;
白眉蝮蛇毒Gln49磷脂酶A_2体外凝血活性
Determination of Thrombin Inhibitor Activity by Absorbance rate of Change;
一种测定凝血酶抑制剂活性的新方法
The Diagnostic Significance of Antithrombin in Disseminated Intravascular Coagulation (DIC)
抗凝血酶活性检测在诊断弥散性血管内凝血中的意义
Mechanisms of Actions of Protease-activated Receptors 1 and 4 in Platelet Activation;
凝血酶受体PAR1与PAR4在血小板活化中的作用机制
Studies on the Thrombin Activatable Fibrinolysis Inhibitor of Coronary Atherosclerotic Heart Disease;
冠心病患者凝血酶激活的纤溶抑制物研究
Influence of Aprotinin to Activated Clotting Time and Whole Blood Prothrombin Time during Cardiopulmonary Bypass;
体外循环下抑肽酶对激活的全血凝固时间和全血凝血酶原时间的影响
Clinical Research on Activation of Platelet and Prothrombin after Transcatheter Closure of Atrial Septal Defects;
房间隔缺损封堵术后血小板活化和凝血酶原激活临床研究
tissue thromboplasti
组织促凝血酶原激酶
thromboplastin antecedent
促凝血酶原激酶先质
Relationship between Thrombin Activated Fibrinolysis Inhibitor in Plasma and Vascular Complication in Type 2 Diabetes;
血浆凝血酶激活的纤溶抑制物与2型糖尿病血管并发症的关系
Nucleocapsid Protein of SARS-associated Coronavirus Upregulates the Transcription of hfgl2 Prothrombinase/ Fibroleukin Gene;
SARS冠状病毒N蛋白激活hfgl2凝血酶原酶基因的研究
